SF
DVAX

Synovus Financial’s Dynavax Technologies DVAX Stock Holding History

Synovus Financial’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,201
Closed -$20K – 878
2020
Q2 		$20K Hold
2,201
– – ﹤0.01% 1101
2020
Q1 		$8K Hold
2,201
– – ﹤0.01% 1629
2019
Q4 		$12K Hold
2,201
– – ﹤0.01% 1182
2019
Q3 		$8K Hold
2,201
– – ﹤0.01% 1215
2019
Q2 		$9K Hold
2,201
– – ﹤0.01% 1130
2019
Q1 		$16K Hold
2,201
– – ﹤0.01% 1037
2018
Q4 		$20K Hold
2,201
– – ﹤0.01% 979
2018
Q3 		$27K Buy
2,201
+201
+10% +$2.72K ﹤0.01% 952
2018
Q2 		$31K Hold
2,000
– – ﹤0.01% 868
2018
Q1 		$40K Buy
+2,000
New +$34.5K ﹤0.01% 812
2017
Q2 		– Sell
-2,000
Closed -$12K – 874
2017
Q1 		$12K Buy
+2,000
New +$9.62K ﹤0.01% 926

Other funds holding DVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Synovus Financial's DVAX Position: Q3 2020 in Review

Synovus Financial sold out of Dynavax Technologies (DVAX) in Q3 2020, closing a stake of 2,201 shares — an estimated $20K sold.

Synovus Financial first reported a position in DVAX in Q1 2017 and held it in 11 quarters. The position peaked at $40K in Q1 2018. 165 funds tracked by Wall St. Rank hold DVAX as of Q3 2020.

  • Synovus Financial reported no remaining Dynavax Technologies position as of Q3 2020 after selling out during the quarter.
  • Synovus Financial sold 2,201 Dynavax Technologies shares in Q3 2020, an estimated $20K.
  • Synovus Financial first reported a position in Dynavax Technologies in Q1 2017 and held it in 11 quarters.
  • Synovus Financial's Dynavax Technologies position peaked at $40K in Q1 2018.
  • 165 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2020.

Based on Synovus Financial's 13F filing for Q3 2020, filed 9 Nov 2020.